Horizon Therapeutics (NASDAQ:HZNP) reported its Q4 earnings results on Tuesday, March 1, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Horizon Therapeutics beat estimated earnings by 5.22%, reporting an EPS of $1.41 versus an estimate of $1.34.
Revenue was up $268.69 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.21 which was followed by a 4.58% drop in the share price the next day.
Here's a look at Horizon Therapeutics's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | 1.54 | 0.88 | 0.04 | 1.05 |
| EPS Actual | 1.75 | 1.62 | 0.03 | 1.28 |
| Revenue Estimate | 979.41M | 685.03M | 330.73M | 690.03M |
| Revenue Actual | 1.04B | 832.55M | 342.41M | 745.31M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
